CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Agena reported that in evaluations performed by its scientific affairs team, the LabChip system “ensured that sufficient DNA was present in the sample to achieve the sensitivity capabilities of the UltraSeek chemistry while efficiently identifying samples compromised by preanalytical variables that could result in false-negative results.”
“Controlling preanalytical variables is an important component of delivering robust reproducible liquid biopsy analysis. The combination of LabChip GX Touch nucleic acid analyzer’s sample qualification with UltraSeek assay’s highly sensitive, multiplexed chemistry delivers a powerful liquid biopsy sample-to-result solution,” Darryl Irwin, senior director of scientific affairs at Agena, said in a press release.